A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

Clinical trial NCT01765088 · UNKNOWN

Trial details

NCT number: NCT01765088
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Anaplastic Oligoastrocytoma Anaplastic Astrocytoma Glioblastoma

Start date: 2012-09-01
Primary completion: 2017-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.